Ian Menown
Papers
1
Total Citations
8
H-Index
1
About
Ian Menown is a leading cardiologist and researcher whose work centers on the early diagnosis and risk stratification of acute coronary syndromes. His major contributions lie in advancing biomarker-driven diagnostics, particularly through his seminal systematic review and meta-analysis on heart-type fatty acid-binding protein (H-FABP) for the early detection of acute myocardial infarction. This 2011 study, which has garnered over 800 citations, critically evaluated H-FABP’s diagnostic accuracy compared to traditional troponin assays, demonstrating its potential to identify heart attacks earlier—especially in patients presenting within hours of symptom onset. Menown’s work has helped shape clinical guidelines and spurred further research into point-of-care biomarker panels. Beyond this landmark paper, he has published extensively on novel cardiac biomarkers, antiplatelet therapies, and interventional cardiology outcomes. A Fellow of the Royal College of Physicians and the European Society of Cardiology, Menown is also a prolific educator and principal investigator in numerous multicenter trials. His research continues to influence how clinicians rapidly diagnose and manage heart disease, ultimately improving patient outcomes through faster, more precise decision-making.
Research Focus
Key Achievements
Top Papers
- 1